Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD). Too much salt in your diet can spell disaster if you suffer from high blood pressure. Research shows that eating less salt in your food can actually improve your heart health. Abbott (NYSE: ABT) announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results. Patients suffering the lethal Hepatitis C disease stand twice as much chance of recovering if they add a new medicine to the existing therapy regiment, a new study has revealed. Researchers from the United States and South Korea have found that patients suffering from Hepatitis B infection stand twice the risk of developing a deadly form of blood cancer called non-Hodgkin lymphoma. Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It can cause chronic liver disease and puts people at high risk from cirrhosis of the liver and liver cancer, according to the WHO. Hepatitis B virus (HBV) and hepatitis C virus (HCV) can be transmitted during intravenous (IV) administration of anesthesia, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. In this study, doctors found that anesthesia contamination â€” not endoscopy contamination â€” was the cause of infection.